Login / Signup

NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors.

Xiang-Yu Meng
Published in: Journal for immunotherapy of cancer (2023)
Keyphrases
  • copy number
  • dna repair
  • clinical decision support
  • human health
  • oxidative stress
  • dna damage
  • risk assessment
  • gene expression
  • genome wide
  • climate change
  • dna methylation